UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Samsung BioLogics files administrative suit to refute accounting fraud ruling
by Nam Doo-hyun
2018-11-28 15:30
Bayer’s liver cancer drug proves efficacy with real-world data
by Nam Doo-hyun
2018-11-27 14:27
Pharmaceuticals, biotechs rise with KOSPI rebound
by Nam Doo-hyun
2018-11-27 11:53
Pharmaceuticals still use credit card kiting for illegal cash rebates
by Nam Doo-hyun
2018-11-26 15:01
Operating income declines at top 10 biotechs on KOSDAQ
by Nam Doo-hyun
2018-11-22 11:15
라인
US data crucial for Korean biosimilars after success in Europe
by Nam Doo-hyun
2018-11-21 15:29
MSD Korea improves employee welfare upon birth of union
by Nam Doo-hyun
2018-11-21 12:56
‘Pay attention to expansion of US online pharmacy market’
by Nam Doo-hyun
2018-11-20 16:05
Samsung BioLogics fiasco hardly affects biotech stocks
by Nam Doo-hyun
2018-11-16 11:30
‘Team up with multinationals to become multinational’
by Nam Doo-hyun
2018-11-15 11:20
라인
Seoul mayor vows to support biomedical industry
by Nam Doo-hyun
2018-11-14 15:34
Orders for ingredients of antitussives, expectorants surge amid fine dust
by Nam Doo-hyun
2018-11-14 11:48
Pharmaceuticals oppose Korea-US FTA’s follow-up steps
by Nam Doo-hyun/So Jae-hyeon
2018-11-12 15:53
'Biosimilar makers to benefit from new research accounting guideline'
by Nam Doo-hyun
2018-11-07 11:23
Market caps of top 20 drugmakers on KOSPI surged this year
by Nam Doo-hyun
2018-11-06 15:41
라인
Will PharmAbcine be new force on KOSDAQ?
by Nam Doo-hyun
2018-11-05 16:32
‘Physicians’ ability to analyze big data, use AI getting crucial’
by Nam Doo-hyun
2018-11-01 16:22
Oriental medical schools fail to get listed on world directory of medical schools
by Nam Doo-hyun
2018-11-01 15:52
'More N. Korean statistics needed for inter-Korean healthcare cooperation’
by Nam Doo-hyun
2018-10-31 15:10
Korea’s drug exports to US inch down this year
by Nam Doo-hyun
2018-10-31 12:22
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top